12-mo DSM-IV MDD and contact coverage | F (p-value) | ||||||
---|---|---|---|---|---|---|---|
Severe (n = 90) | Mild/moderate (n = 74) | Any severity (n = 164) | |||||
n | % (SE) | n | % (SE) | n | % (SE) | ||
Among those with 12-mo MDD, receiving antidepressant medicationa | 47 | 47.2 (6.7) | 26 | 40.1 (7.7) | 73 | 43.9 (5.2) | 0.51 (0.48) |
At least partially adequate pharmacotherapy1 | 37 | 81.0 (7.6) | 23 | 95.5 (3.1) | 60 | 87.1 (5.1) | 4.13 (0.05)* |
Adequate pharmacotherapy2 | 21 | 48.3 (12.0) | 11 | 56.7 (12.8) | 32 | 51.8 (9.0) | 0.23 (0.63) |
Among those with 12-mo MDD, receiving any psychotherapya | 39 | 47.3 (6.5) | 22 | 33.0 (6.2) | 61 | 40.7 (5.0) | 2.98 (0.10) |
At least partially adequate psychotherapy3 | 32 | 79.3 (8.5) | 19 | 93.6 (4.6) | 51 | 84.6 (5.7) | 2.16 (0.15) |
Adequate psychotherapy4 | 30 | 75.0 (9.2) | 19 | 93.6 (4.6) | 49 | 81.9 (6.2) | 3.17 (0.09) |